Silver Spring drugmaker United Therapeutics Corp. extended an exclusive license with drug giant Eli Lilly & Co. to cover its pulmonary hypertension drug Adcirca, which will lose part of its patent protection later this year.
{iframe}http://www.bizjournals.com/washington/news/2017/05/19/united-therapeutics-reworks-deal-ahead-of-a-key.html?ana=e_me_set1&s=newsletter&ed=2017-05-19&u=tgsFWC4bmAJifJaD7aSENg0a82e31f&t=1495467311&j=78206601{/iframe}